Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 147 publications
Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia.
Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemia.
Journal: Blood cancer journal
Published: April 12, 2026
Challenges and approaches in the diagnosis and differential diagnosis of atypical CLL: A response to 'Defining atypical CLL for reproducible diagnosis: Implications of the work by Wang et al.'
Journal: Cytometry. Part B, Clinical cytometry
Published: December 04, 2025
Mature T-cell leukemia/lymphoma with an NK-like immunophenotype: A report of 7 cases.
Journal: Cytometry. Part B, Clinical cytometry
Published: November 26, 2025
The Power of Flow Cytometry in the Cytopathologic Diagnosis of Lymphoid Lesions.
Journal: Acta cytologica
Published: November 04, 2025
Lineage switch of B-lymphoblastic leukemia with KMT2A::AFF1 fusion into acute myelomonocytic leukemia under blinatumomab therapy.
Journal: Leukemia & lymphoma
Published: September 08, 2025
Immunophenotypic, cytogenetic, and mutational features of chronic lymphocytic leukemia/small lymphocytic lymphoma with atypical immunophenotype.
Journal: Cytometry. Part B, Clinical cytometry
Published: August 01, 2025
Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort.
Journal: Archives of pathology & laboratory medicine
Published: May 19, 2025
The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes.
Journal: Archives of pathology & laboratory medicine
Published: November 01, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia.
Journal: Leukemia & lymphoma
Published: May 15, 2024
Advancing Diagnostic Accuracy and Quality of Patient Care Through the Implementation of a Flow Cytometry Quality Assurance Program.
Journal: Archives of pathology & laboratory medicine
Published: May 15, 2024
CD133 in T-lymphoblastic leukemia is preferentially expressed in early T-phenotype (ETP) and near ETP subtypes.
Journal: Cytometry. Part B, Clinical cytometry
Published: May 11, 2024
Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement.
Journal: American journal of clinical pathology
Published: November 24, 2023
Last Updated: 09/26/2026